Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Probiotic Clostridium butyricum therapy enhanced the efficacy of ICB in patients with NSCLC
Tomita et al. 2020 Cancer Immunology Research 8: 1236
Probiotic Clostridium butyricum therapy improved ICB efficacy in antibiotic-treated patients
Tomita et al. 2020 Cancer Immunology Research 8: 1236
Preliminary data suggest that altering the gut microbiome might prevent colitis associated with immune checkpoint inhibitors.
see also:
[Akkermansia muciniphila & Immune Checkpoint Inhibitors (ICIs) Therapy (to improve)](brain://sKPRlF2AbUSWmaj5kqJoWQ/Akkerma…